Comparison among four immobilization devices for whole breast irradiation with Helical Tomotherapy
Comparison among four immobilization devices for whole breast irradiation with Helical Tomotherapy
复制标题
DOI:
10.1016/j.ejmp.2019.12.023
复制
发表时间:
2020-01-01
影响因子:
3.4
通讯作者:
Racadot, Severine
中科院分区:
文献类型:
--
作者:
Biston, Marie-Claude;Jarril, Jimmy;Racadot, Severine
Purpose: To evaluate the repositioning accuracy of 4 immobilization devices (ID) used for whole breast Helical Tomotherapy treatments: arm float with VacFix (R) (Par Scientific, Denmark), all-in-one (R) (AIO (R)) system (Orfit, Belgium), MacroCast thermoplastic mask (Macromedics, The Netherlands) and BlueBag (R) system with ArmShuttle (Elekta, Sweden).Materials and methods: Twenty four women with breast cancer with PTV including the breast/chest wall and lymph nodes were involved in this study (6 women per group). Pretreatment registration results were first collected using automatic bone registration + manual adjustment on the vertebra followed by independent registrations on different ROIs representing each treated area (axillary, mammary chain, clavicular, breast/chest wall). The differences in translations and rotations between reference registration and the above mentionned ROIs were calculated. A total of 120 MVCT images were analyzed.Results: Significant differences were found between IDs (p < 0.0001), ROIs (p = 0.0002) and the session number (p < 0.0001) on the observed shifts, when examining 3D translation vectors. 3D-vectors were significantly lower for the BlueBag (R) than for the VacFix (R) or for the AIO (R) (p < 0.0001), but differences were not significant compared to the mask (p = 0.674). Finally, setup margins were overall smaller for the BlueBag (R) than for other IDs, with values ranging from 1.53 to 1.91 mm on the mammary chain area, 4.52-6.07 mm on the clavicular area, 2.71-4.62 mm on the axillary area, and 3.39-5.10 mm on the breast.Conclusion: We demonstrated in this study that the BlueBag (R) combined with arm shuttle is a robust solution for breast and nodes immobilization during HT treatments.